Clinical Trial Update: Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial update on safety and efficacy of GRT6005 for pain due to diabetic polyneuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy
• Pain

Drugs mentioned

• GRT6005

Snippet

Sponsor: Tris Pharma, Inc. | Conditions: Pain, Diabetic Neuropathies | Phase 2 | Status: COMPLETED